Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study
Background. Anemia during pregnancy is commonly caused by iron deficiency and can have severe consequences for both the mother and the developing fetus. The aim of this retrospective study was to assess the safety and efficacy of intravenous ferric carboxymaltose (FCM) in pregnant women. Methods. Al...
Saved in:
Main Authors: | Anouk Pels, Wessel Ganzevoort |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2015/728952 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women
by: Saleema Wani, et al.
Published: (2019-01-01) -
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
by: Melvin H. Seid, et al.
Published: (2017-01-01) -
The experiences of ferric carboxymaltose desensitization and provocation
by: Fatma Dindar Çelik, MD, et al.
Published: (2025-02-01) -
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
by: Iftikhar Hussain, et al.
Published: (2013-01-01) -
Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
by: Aysun Seker, et al.
Published: (2025-01-01)